Order of the President of the General Court of 15 December 2014 — August Wolff and Remedia v Commission

(Case T-672/14 R)

((Application for interim measures - Marketing authorisation for medicinal products for human use - Application for suspension of operation of a measure - Lack of urgency))

(2015/C 081/27)

Language of the case: German

Parties

Applicants: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany); and Remedia d.o.o (Zagreb, Croatia) (represented by: P. Klappich, C. Schmidt and P. Arbeiter, lawyers)

Defendant: European Commission (represented by: M. Šimerdová, A. Sipos and B.-R. Killmann, acting as Agents)

Re:

Application for the suspension of the operation of Commission Implementing Decision C (2014) 6030 final of 19 August 2014 concerning marketing authorisations for topical medicinal products for human use containing high concentrations of estradiol pursuant to Article 31 of Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67).

Operative part of the order